Addictions, Drug & Alcohol Institute


October 13, 2022

ADAI’s Dr. Susan Stoner Appointed as Holder Ann Streissguth Endowed Professorship in FASD

Photo of Dr. Stoner and text Congratulations to Dr Susan Stoner, holder of the Ann Streissguth Endowed Professorship in FASD. ADAI and UW Psychiatry logos

In 1973, UW pediatricians Kenneth L. Jones, David W. Smith, and Christy Ulleland, along with psychologist Ann Streissguth, published a landmark study of 8 children born with serious disabilities and a specific pattern of birth defects that could only have been caused during gestational development – all 8 had alcoholic mothers. Jones and Smith named…

October 5, 2022

ADAI in the News: Dr. Beatriz Carlini’s Work on High-THC Cannabis Profiled in the Seattle Times

Image of "shatter" cannabis product with cannabis leaf resting at side and text Researchers warn of mental health risks of high-potency cannabis, Seattle Times, Oct 4, 2022

Seattle Times reporter Hannah Furfaro attended our recent ADAI Symposium on High-THC Cannabis in Legal Regulated Markets, then spoke to the Director of ADAI’s Cannabis Education & Research Project (CERP), Beatriz Carlini, PhD, MPH, as well as several other presenters at the symposium, for this article in the Seattle Times: Researchers warn of mental health…

June 29, 2022

New Look for!

Screenshot from new homepage

ADAI and the CEDEER team are excited to launch a new version of our website, Check out the webpage and let us know what you think! Features of the new site include: Improved navigation and organization Better accessibility Translation into 20 different languages (by Google Translate) The redesign work was done by Heather Larson at Day…

June 17, 2022

ADAI in the News: High THC Concentration Products (Bia Carlini) and Safer Smoking Kits (Caleb Banta-Green)

Hand holding cell phone with website loaded on the screen reading NEWS at the top

High THC Concentration Products are a “Time Bomb” ADAI Research Scientist Beatriz Carlini, PhD, MPH was interviewed for an article in The Times (UK) about high THC concentration products and how it’s a “time bomb” in terms of its potential effects on the mental health of people who use it. “We are not paying attention…

June 6, 2022

Get Free Naloxone by Mail in WA State

Hand holding a nasal narcan kit

Do you have naloxone (a.k.a. Narcan) in your first aid kit? This medication is given when an opioid overdose happens and can help save someone’s life. Anyone who uses opioids (even if they are prescribed by a physician) or who has friends or family who do should have naloxone on hand just in case. Additionally,…

May 23, 2022

ADAI in the News: How to Keep Loved Ones Safe from Fentanyl (NY Times)

Father talking to son on steps

ADAI Principal Research Scientist Caleb Banta-Green was interviewed by Melinda Wenner Moyer at the New York Times for this piece about how to talk about opioids with your family. Dr. Banta-Green talks about how widely and safely fentanyl is used in hospitals – “most people who have had a day surgery have had fentanyl” –…

May 9, 2022

Why ADAI is Using “Cannabis” Instead of “Marijuana”

Blocks spelling out "Words matter"

Words matter. And that’s why we’re working to replace the term “marijuana” on ADAI websites and resources with “cannabis,” following the recent passing of Washington State’s HB 1210. This new law makes Washington State a pioneer on removing discriminatory language from cannabis-related official documents in the United States. The term “marijuana” came into popular usage in the U.S….

May 4, 2022

Get News, Events, & Research Updates on Opioids & Stimulants from CEDEER

Subscribe to our newsletter

The Center for Community-Engaged Drug Education, Epidemiology and Research (CEDEER) group at ADAI joins research with the “real-world” to generate innovative, evidence-based, and person-centered responses to the use of opioids, stimulants and other illicit substances. The group works to collect and share knowledge gained from research, local data, clinical expertise, and personal lived experiences of…

May 2, 2022

ADAI in the News: High-Potency Cannabis a Concern in WA and CO

Cannabis pen

ADAI cannabis expert Beatriz Carlini, PhD, MPH was interviewed for a national NBC News article exploring the impact of high-THC concentration products in states that have legalized cannabis for retail sale, like Washington and Colorado. Dr. Carlini, who was part of a team of UW and WSU researchers who put together a consensus statement and…

March 8, 2022

Results from the 2021 WA State Syringe Service Program Health Survey

Title of report with map showing location of survey respondents

The biennial WA State Syringe Service Program Health Survey is the state’s primary source of data on the substance use patterns, health behaviors, and health care needs of people who use drugs and utilize syringe service programs (SSPs). The University of Washington’s Addictions, Drug & Alcohol Institute (ADAI) conducts the survey in collaboration with Public…

Previous page Next page